The Use of 4‐Aminopyridine (Fampridine) in Demyelinating Disorders

Lignende værker

• Sustained-Release Fampridine (4-Aminopyridine) in Multiple Sclerosis: Efficacy and Impact on Motor Function
  af: Rabadi, Meheroz H., et al.
  Udgivet: (2013)
• Dynamic walking features and improved walking performance in multiple sclerosis patients treated with fampridine (4-aminopyridine)
  af: Keune, Philipp M., et al.
  Udgivet: (2015)
• The effects of 4-aminopyridine and tetraethylammonium ions on normal and demyelinated mammalian nerve fibres.
  af: Bostock, H, et al.
  Udgivet: (1981)
• Acute axon damage and demyelination are mitigated by 4-aminopyridine (4-AP) therapy after experimental traumatic brain injury
  af: Kryslaine L. Radomski, et al.
  Udgivet: (2022-05-01)
• A comparison of the facilitatory actions of 4-aminopyridine methiodide and 4-aminopyridine on neuromuscular transmission.
  af: Horn, A S, et al.
  Udgivet: (1979)